Video of the Week: Perampanel Reduces Seizure Frequency

Daily adjunctive therapy with the investigational oral drug perampanel significantly reduced the frequency of seizures by 5%-14%, compared with placebo. The data come  from a multinational phase III clinical trial of 388 patients with hard-to-control epilepsy that was presented at the annual meeting of the American Academy of Neurology.

Patients in the study had uncontrolled epilepsy despite being on one to three other antiseizure drugs, and they continued their usual medications during the trial, according to study investigator Dr. Jacqueline A. French.

Our reporter Sherry Boschert talked with Dr. Marc Nuwer, professor of neurology at the University of California, Los Angeles, who said that the most exciting thing about perampanel is that it establishes a new category of drugs.

You can read more about the study by visiting Clinical Psychiatry News online.

Leave a comment

Filed under Clinical Psychiatry News, IMNG, Psychiatry, Video

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s